| Literature DB >> 29030769 |
Diego Franciotta1, Matteo Gastaldi2, Luana Benedetti3, Giampaola Pesce3, Tiziana Biagioli4, Francesco Lolli5, Gianna Costa6, Cristina Melis6, Francesca Andreetta7, Ornella Simoncini7, Claudia Giannotta8, Elena Bazzigaluppi9, Raffaella Fazio9, Roberta Bedin10, Diana Ferraro10, Sara Mariotto11, Sergio Ferrari11, Elisabetta Galloni12, Valentina De Riva12, Elisabetta Zardini2, Andrea Cortese2, Eduardo Nobile-Orazio8.
Abstract
This document presents the guidelines for anti-ganglioside antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Main clinical information on dysimmune peripheral neuropathies, indications and limits of anti-ganglioside antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.Entities:
Keywords: Laboratory diagnostics; Neurological autoimmune diseases; Peripheral nervous system
Mesh:
Substances:
Year: 2017 PMID: 29030769 DOI: 10.1007/s10072-017-3025-3
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307